Norgine BV (Amsterdam) has acquired the distribution rights of the product portfolio of SpePharm Holding.

Norgine BV has acquired the distribution rights of SAVENE®, XEROTIN®, PROther® and the DANTRIUM® brands. These products will be commercialised through Norgine’s pharmaceutical infrastructure, which spans all of the major markets of Europe.

SpePharm Holding has, over the past few years, built an interesting portfolio of important hospital products. Because of its more substantial infrastructure in Europe, Norgine will be able to significantly increase the commercial support given to these products while at the same time strengthening the promotion of Norgine’s existing products.

Please visit the Norgine website for additional information:


As a result of this change, we would like to notify you of the contact details where you can send any safety information you become aware of related to SAVENE®, XEROTIN®, PROther® and DANTRIUM®.
All such information can be forwarded to:

All Medical Information & Safety Enquiries:

Email: medinfo-enquiries@norgine.com
Freephone Number: 00 800 1200 2222
Alternative Telephone Number +44 (0) 1748 828890 (calls charged at international rate)

For All Commercial, Distribution and Sales Enquiries:
Email: customerservicescp@norgine.com
Tel: +44 (0) 1895 826790

Website by College Hill - Life Sciences